BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32741899)

  • 1. Exacerbation of gefitinib-induced liver injury by glutathione reduction in mice.
    Oda S; Miyazaki N; Tsuneyama K; Yokoi T
    J Toxicol Sci; 2020; 45(8):493-502. PubMed ID: 32741899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats.
    Iida A; Sasaki E; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2015 Jul; 43(7):958-68. PubMed ID: 25870103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
    Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
    J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepatic damage by reactive metabolites--with consideration of circadian variation of murine hepatic glutathione levels.
    Mori K; Kumano A; Kodama T; Takiguchi S; Takano N; Kumada K; Hatao K; Kimura T
    J Toxicol Sci; 2014 Aug; 39(4):537-44. PubMed ID: 25056778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
    Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mouse model for phenytoin-induced liver injury: involvement of immune-related factors and P450-mediated metabolism.
    Sasaki E; Matsuo K; Iida A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Toxicol Sci; 2013 Nov; 136(1):250-63. PubMed ID: 23986454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione.
    Mizutani T; Nomura H; Nakanishi K; Fujita S
    Toxicol Appl Pharmacol; 1987 Jan; 87(1):166-76. PubMed ID: 3798451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione modulation and oxidative stress in human liver slices.
    Vickers AE; Fisher RL; Sinclair JR
    Curr Drug Discov Technol; 2010 Sep; 7(3):154-69. PubMed ID: 20843295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain and interindividual differences in lamotrigine-induced liver injury in mice.
    Akai S; Oda S; Yokoi T
    J Appl Toxicol; 2019 Mar; 39(3):451-460. PubMed ID: 30325050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1.
    Lu Y; Cederbaum AI
    Toxicol Sci; 2006 Feb; 89(2):515-23. PubMed ID: 16251482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice.
    Shimizu S; Atsumi R; Itokawa K; Iwasaki M; Aoki T; Ono C; Izumi T; Sudo K; Okazaki O
    Arch Toxicol; 2009 Jul; 83(7):701-7. PubMed ID: 19479240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of oxidative stress in paraquat-induced metallothionein synthesis under glutathione depletion.
    Nakagawa I; Suzuki M; Imura N; Naganuma A
    Free Radic Biol Med; 1998 Jun; 24(9):1390-5. PubMed ID: 9641256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p-Dichlorobenzene-induced hepatotoxicity in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Nakahori Y; Yamamoto K
    Toxicology; 1994; 94(1-3):57-67. PubMed ID: 7801330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glutathione production by L-S,R-buthionine sulfoximine activates hepatic ascorbate synthesis - A unique anti-oxidative stress mechanism in mice.
    Yu M; Liu Y; Duan Y; Chen Y; Han J; Sun L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 484(1):56-63. PubMed ID: 28115164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine-induced hepatotoxicity in a GSH-depleted rat model.
    Shimizu S; Atsumi R; Nakazawa T; Izumi T; Sudo K; Okazaki O; Saji H
    Arch Toxicol; 2011 Apr; 85(4):347-53. PubMed ID: 20871981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.
    Jiang LL; Jiang Y; Zhao DS; Fan YX; Yu Q; Li P; Li HJ
    Chem Res Toxicol; 2018 Oct; 31(10):1052-1060. PubMed ID: 30203651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glutathione depletion on metallothionein synthesis induced by paraquat in mice.
    Nakagawa I; Suzuki M; Yanagiya T; Imura N; Naganuma A
    Tohoku J Exp Med; 1995 Nov; 177(3):249-62. PubMed ID: 8966720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.